Management Board meeting: 12 March 2026, European Medicines Agency, Amsterdam, the Netherlands, 12 March 2026

Orphan medical devices regular process: Guide for applicants

Orphan medical devices regular process: 2026 timetable

Clinical advice request: Template for applicants

Orphan status request: Template for applicants

Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 40, Status: Authorised

Scientific Advisory Group on Immune and Inflammatory Diseases

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

Implantable cardiac devices (various) - Notified body 2797 - 15/07/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment